FILTER

Refine your search with the following facets to narrow down your results.

4 Current news of Bausch & Lomb

Bausch + Lomb Names Daniel M. Wechsler as Global President, Pharmaceuticals

13-Sep-2010 - Bausch + Lomb has named Daniel M. Wechsler as corporate vice president and global president of its Pharmaceuticals business. Mr. Wechsler was most recently head of U.S. Strategy, Commercial Model Innovation and Business Development for Merck & Co., a role to which he was appointed following the ...

business development education gynecology +2

Bausch & Lomb Japan Names Mitsuo Hirose as Chairman

06-Apr-2009 - Bausch & Lomb Japan has named Mitsuo (Mike) Hirose as chairman, effective immediately. Mr. Hirose has served on the subsidiary’s Board of Directors since January 2009. Mr. Hirose brings executive experience to Bausch & Lomb Japan, complementing the company’s existing leadership team. Most ...

consultancy

Bausch & Lomb and Galapagos sign agreement to collaborate on ophthalmic disease research

14-Apr-2008 - Bausch & Lomb and Galapagos NV announced that they have entered into a collaborative research agreement. Bausch & Lomb will have the exclusive option to license select Galapagos compounds as development candidates for therapeutic uses in ophthalmic diseases. "The agreement provides access to a ...

diseases milestone payments research agreements

Bausch & Lomb Licenses rPlasmin from Talecris Biotherapeutics for Ophthalmic Use

30-Aug-2006 - Bausch & Lomb and Talecris Biotherapeutics announced that Talecris has granted an exclusive worldwide license to Bausch & Lomb for recombinant Plasmin technology for use in ophthalmology. The companies will co-develop rPlasmin, a recombinant derivative of the human blood component Plasmin, which ...

clinical trials milestone payments ophthalmology